Western Institutional Review Board, Inc.

Western Institutional Review Board, Inc.

Western Institutional Review Board, Inc.

Overview
Date Founded

1977

Headquarters

1019 39th Avenue SE,Suite 120,Puyallup, WA 98374-2115

Type of Company

Private

Industries

Market & Policy Research
Other Business & Consulting Services
Medical Products & Equipment
Management Consulting

Company Description

Western Institutional Review Board, Inc. provides clinical research, review, and individual investigation services. It is a provider of review services to academic centers, hospitals, networks, and in-house biotech research institutions, as well as for individual investigators. The company offers regulatory skills for the development of research protocols and documentation. Western Institutional Review Board was founded in 1968 by Angela J. Bowen and is headquartered in Olympia, WA.

Contact Data
Trying to get in touch with decision makers at Western Institutional Review Board, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Operating Officer & Chief Financial Officer

Company Secretary & General Counsel

Director-Human Resources & Communications

Director-Regulatory Affairs

Director, Enterprise Programs Development

Chairman & President

Chief Compliance Officer

Account Executive

Director-International Fellows Program

Director

Board of Directors

Chairman & Chief Executive Officer at WIRB-Copernicus Group, Inc.

Senior Partner Healthcare Team at Arsenal Capital Management LP

Managing Director at Providence Equity Partners LLC

Paths to Western Institutional Review Board, Inc.
Potential Connections via
Relationship Science
You
Western Institutional Review Board, Inc.
Transaction Advisors
Investment Advisor

Advised onArsenal Capital Management LP purchases Western Institutional Review Board, Inc. from BV Investment Partners LLC

Advisors & Consultants
Legal Advisor

Partner at Morgan, Lewis & Bockius LLP

Investors
Details Hidden

New Canaan Funding focuses on mezzanine investments in the middle-market private equity market. The firm provides subordinated debt for acquisitions, recapitalizations and growth financings

Details Hidden

Frazier Management invests in lower middle-market healthcare companies with $5-50 million in EBITDA and makes equity commitments ranging from $30-350 million. Investments take the form of buyouts, recapitalizations and corporate carveouts.

Details Hidden

BV Investment Partners LLC (BV) invests in middle market companies located in the US with an average EBITDA of $5 to $20 million and transaction value of $30 to $150 million. The firm targets companies operating in the fields tech-enabled business services, software and IT services sectors. It provides financing for buyout and growth transactions with a minimum investment size of $25 million. It makes control investments and acquires majority or minority stake in the company.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Western Institutional Review Board, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Western Institutional Review Board, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Western Institutional Review Board, Inc..